Literature DB >> 8020937

Localization of the squalene synthase gene (FDFT1) to human chromosome 8p22-p23.1.

I Shechter1, D G Conrad, I Hart, R C Berger, T L McKenzie, J Bleskan, D Patterson.   

Abstract

Recently, we reported the isolation of a cDNA encoding the human enzyme squalene synthase, the first step of sterol biosynthesis uniquely committed to synthesis of cholesterol (6). As such, it is likely that this enzyme occupies a critical regulatory position in the synthesis of cholesterol. As part of continuing studies of the role of this gene in cellular metabolism, we undertook the mapping of this gene on the human chromosomes. To localize the gene, we have first isolated a yeast artificial chromosome (YAC) containing the squalene synthase gene. We then used fluorescence in situ hybridization (FISH) with yeast DNA containing the YAC to localize the gene to chromosome 8. Assignment to human chromosome 8 was confirmed by polymerase chain reaction analysis of a somatic cell hybrid containing human chromosome 8. Use of a somatic cell hybrid regional mapping panel dividing chromosome 8 into several fragments localized the gene to 8p21-pter. Fractional length analysis of the FISH mapping placed the signal generated with this YAC at 8p22-p23.1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8020937     DOI: 10.1006/geno.1994.1135

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  15 in total

1.  Cloning, sequencing, and analysis of inv8 chromosome breakpoints associated with recombinant 8 syndrome.

Authors:  S L Graw; T Sample; J Bleskan; E Sujansky; D Patterson
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

2.  Genetic and physical mapping of the progressive epilepsy with mental retardation (EPMR) locus on chromosome 8p.

Authors:  S Ranta; A E Lehesjoki; A Hirvasniemi; J Weissenbach; B Ross; S M Leal; A de la Chapelle; T C Gilliam
Journal:  Genome Res       Date:  1996-05       Impact factor: 9.043

3.  Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.

Authors:  Naga Chalasani; Xiuqing Guo; Rohit Loomba; Mark O Goodarzi; Talin Haritunians; Soonil Kwon; Jinrui Cui; Kent D Taylor; Laura Wilson; Oscar W Cummings; Yii-Der Ida Chen; Jerome I Rotter
Journal:  Gastroenterology       Date:  2010-08-11       Impact factor: 22.682

4.  Squalene Synthase Deficiency: Clinical, Biochemical, and Molecular Characterization of a Defect in Cholesterol Biosynthesis.

Authors:  David Coman; Lisenka E L M Vissers; Lisa G Riley; Michael P Kwint; Roxanna Hauck; Janet Koster; Sinje Geuer; Sarah Hopkins; Barbra Hallinan; Larry Sweetman; Udo F H Engelke; T Andrew Burrow; John Cardinal; James McGill; Anita Inwood; Christine Gurnsey; Hans R Waterham; John Christodoulou; Ron A Wevers; James Pitt
Journal:  Am J Hum Genet       Date:  2018-06-14       Impact factor: 11.025

Review 5.  Pediatric fatty liver disease: role of ethnicity and genetics.

Authors:  Pierluigi Marzuillo; Emanuele Miraglia del Giudice; Nicola Santoro
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

6.  Human steroidogenic acute regulatory protein: functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and a pseudogene to chromosome 13.

Authors:  T Sugawara; J A Holt; D Driscoll; J F Strauss; D Lin; W L Miller; D Patterson; K P Clancy; I M Hart; B J Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

7.  Genetic polymorphisms in the mevalonate pathway affect the therapeutic response to alendronate treatment in postmenopausal Chinese women with low bone mineral density.

Authors:  C Wang; H Zheng; J-W He; H Zhang; H Yue; W-W Hu; J-M Gu; C Shao; W-Z Fu; Y-Q Hu; M Li; Y-J Liu; Z-L Zhang
Journal:  Pharmacogenomics J       Date:  2014-09-16       Impact factor: 3.550

8.  Physical mapping of the holoprosencephaly critical region in 21q22.3, exclusion of SIM2 as a candidate gene for holoprosencephaly, and mapping of SIM2 to a region of chromosome 21 important for Down syndrome.

Authors:  M Muenke; L J Bone; H F Mitchell; I Hart; K Walton; K Hall-Johnson; E F Ippel; J Dietz-Band; K Kvaløy; C M Fan
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

9.  The association between hepatic fat content and liver injury in obese children and adolescents: effects of ethnicity, insulin resistance, and common gene variants.

Authors:  Nicola Santoro; Ariel E Feldstein; Erik Enoksson; Bridget Pierpont; Romy Kursawe; Grace Kim; Sonia Caprio
Journal:  Diabetes Care       Date:  2012-12-28       Impact factor: 19.112

10.  Studies of CTNNBL1 and FDFT1 variants and measures of obesity: analyses of quantitative traits and case-control studies in 18,014 Danes.

Authors:  Camilla Helene Andreasen; Mette Sloth Mogensen; Knut Borch-Johnsen; Annelli Sandbaek; Torsten Lauritzen; Katrine Almind; Lars Hansen; Torben Jørgensen; Oluf Pedersen; Torben Hansen
Journal:  BMC Med Genet       Date:  2009-02-26       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.